The Corneal Implants Market To Grow On An Exceptional NotePosted by Merin John on June 24th, 2021 The use of corneal implants is gathering momentum around the world, owing to their proven efficacy for the correction of presbyopia by improving near and intermediate vision without any detriment to distant vision. Corneal implants are the most promising device used for refractive surgery, which brings about a change to improve the patient’s quality of life, besides being safe, effective, reversible, and minimally invasive. Introduction of newer material with enhanced biocompatibility along with advancements in related technology has amplified the success of corneal implants for visually impaired patients. Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/31340 Company Profiles
Corneal implants have gained clinical significance on the basis of fewer risks associated with corneal inlay surgery as compared to intraocular surgery, faster visual recovery, and being more biomechanically stable. The global corneal implants market was valued at US$ 18.5 Mn in 2018, and is expected to exhibit a high CAGR of 13% during the forecast period (2019–2029). Key Takeaways of Corneal Implants Market Study
“The global market for corneal implants increases parallel with the fast-increasing presbyopic population. Wider array of approaches is being seen with corneal implants due to continuous advancements in technology,” says a PMR analyst. Acquisition – Strategic Focus of Corneal implant Manufacturers Various players in the corneal implant market are focusing on inorganic growth strategies such as acquisitions and partnerships. These activities have played a vital role in the expansion of businesses and increased customer base of market players. For example, in August 2016, Presbia PLC, an ophthalmic device company and leader in near-vision restoration, completed the acquisition of Neoptics AG, including its intellectual property portfolio. In March 2018, SightLife Surgical acquired AcuFocus, whose Kamra corneal inlay was the first to receive FDA approval, designed for the surgical correction of presbyopia. These winning strategies by leading players are also being followed by regional and local players. More Valuable Insights on Corneal Implants Market The study provides compelling insights on the corneal implants market on basis of implant type (small aperture corneal implantable devices, corneal reshaping implantable devices, and refractive corneal implantable devices), end user (ophthalmic clinics, ambulatory surgical centers, and hospitals), and indication (presbyopia, hypermetropia, myopia, and astigmatism), across seven major regions. Like it? Share it!More by this author |